Merrimack Pharmaceuticals
MACK
#7959
Rank
โ‚ฌ0.21 B
Marketcap
14,38ย โ‚ฌ
Share price
0.00%
Change (1 day)
18.48%
Change (1 year)

Revenue for Merrimack Pharmaceuticals (MACK)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Merrimack Pharmaceuticals from 2010 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A-100%
2016 โ‚ฌ58.22 M-28.68%
2015 โ‚ฌ81.63 M-3.38%
2014 โ‚ฌ84.48 M144.17%
2013 โ‚ฌ34.6 M-6.44%
2012 โ‚ฌ36.98 M40.37%
2011 โ‚ฌ26.34 M72.59%
2010 โ‚ฌ15.26 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ50.85 BN/A๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ89.65 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ28.02 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.12 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.56 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA